Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27677314)

Published in Iran Biomed J on September 28, 2016

Authors

Yeganeh Talebkhan1, Mohsen Doozbakhshan1, Samaneh Saberi1, Maryam Esmaeili1, Najmeh Karami1, Nazanin Mohajerani1, Afshin Abdirad2, Mahmoud Eshagh Hosseini3, Azin Nahvijou4, Mohammad Ali Mohagheghi4, Marjan Mohammadi1

Author Affiliations

1: HPGC Group, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
2: Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
3: Department of Gastroenterology, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
4: Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Articles citing this

Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population. Int J Mol Epidemiol Genet (2017) 0.75

Articles cited by this

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37

Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer (1997) 5.80

The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02

Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97

The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest (2006) 1.93

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol (1999) 1.53

Helicobacter pylori multiplex serology. Helicobacter (2009) 1.29

The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol (2008) 1.25

The neutrophil-activating Dps protein of Helicobacter pylori, HP-NAP, adopts a mechanism different from Escherichia coli Dps to bind and condense DNA. Nucleic Acids Res (2007) 1.18

The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol Med Microbiol (2007) 1.13

Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun (2006) 1.11

Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein. J Allergy Clin Immunol (2008) 1.08

CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J Gastroenterol (2007) 0.97

Helicobacter pylori, asthma and allergy. FEMS Immunol Med Microbiol (2009) 0.97

A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer (2013) 0.95

Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br J Dermatol (2012) 0.93

Goseki histological grading of gastric cancer is an important predictor of outcome. Gut (1994) 0.93

Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer. World J Gastroenterol (2009) 0.92

The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? Toxicon (2009) 0.91

Up-expression of NapA and other oxidative stress proteins is a compensatory response to loss of major Helicobacter pylori stress resistance factors. Free Radic Res (2005) 0.90

Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ (2015) 0.89

Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications. World J Gastroenterol (2014) 0.88

Association between IL-4 -590C>T polymorphism and gastric cancer risk. Tumour Biol (2013) 0.88

Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies. World J Gastroenterol (2008) 0.85

Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85

Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World J Gastroenterol (2005) 0.84

Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathog (2014) 0.83

Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein. Med Microbiol Immunol (2006) 0.82

Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. Int J Epidemiol (2016) 0.82

Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects. Infect Immun (2013) 0.82

Human gastric epithelium produces IL-4 and IL-4delta2 isoform only upon Helicobacter pylori infection. Int J Immunopathol Pharmacol (2008) 0.81

An Update on Helicobacter pylori as the Cause of Gastric Cancer. Gastrointest Tumors (2014) 0.80

Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis. Onco Targets Ther (2016) 0.78

Interleukin (IL)-4 -590C>T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysis. Ann Med Surg (Lond) (2016) 0.78

The ability of Helicobacter pylori to activate neutrophils is determined by factors other than H. pylori neutrophil-activating protein. J Infect Dis (2000) 0.77

A Recombinant DNA Plasmid Encoding the sIL-4R-NAP Fusion Protein Suppress Airway Inflammation in an OVA-Induced Mouse Model of Asthma. Inflammation (2016) 0.77

Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. Int J Immunopathol Pharmacol (2012) 0.77

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model. J Vis Exp (2015) 0.76